141 related articles for article (PubMed ID: 20013077)
1. A mimic of phosphorylated prolactin inhibits human breast cancer cell proliferation via upregulation of p21 waf1.
Xie W; He Y; Huo D; Huang Y; Wu W
Med Oncol; 2010 Dec; 27(4):1340-5. PubMed ID: 20013077
[TBL] [Abstract][Full Text] [Related]
2. S179D prolactin sensitizes human prostate cancer cells such that physiological concentrations of 1, 25 dihydroxy vitamin D3 result in growth inhibition and cell death.
Wu W; Zanello L; Walker AM
Prostate; 2007 Oct; 67(14):1498-506. PubMed ID: 17680631
[TBL] [Abstract][Full Text] [Related]
3. S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells.
Wu W; Ginsburg E; Vonderhaar BK; Walker AM
Cancer Res; 2005 Aug; 65(16):7509-15. PubMed ID: 16103106
[TBL] [Abstract][Full Text] [Related]
4. Different forms of prolactin have opposing effects on the expression of cell cycle regulatory proteins in differentiated mammary epithelial cells.
Wu W; Chen YH; Ueda E; Tan D; Bartolini P; Walker AM
Oncol Res; 2006; 16(2):75-84. PubMed ID: 16898268
[TBL] [Abstract][Full Text] [Related]
5. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.
Wu W; Coss D; Lorenson MY; Kuo CB; Xu X; Walker AM
Biochemistry; 2003 Jun; 42(24):7561-70. PubMed ID: 12809512
[TBL] [Abstract][Full Text] [Related]
6. A mimic of phosphorylated prolactin induces apoptosis by activating AP-1 and upregulating p21/waf1 in human prostate cancer PC3 cells.
DU L; Wu W
Oncol Lett; 2012 Nov; 4(5):1064-1068. PubMed ID: 23162652
[TBL] [Abstract][Full Text] [Related]
7. 1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma.
Wu W; Zhang X; Zanello LP
Cancer Lett; 2007 Aug; 254(1):75-86. PubMed ID: 17412493
[TBL] [Abstract][Full Text] [Related]
8. S179D prolactin primarily uses the extrinsic pathway and mitogen-activated protein kinase signaling to induce apoptosis in human endothelial cells.
Ueda EK; Lo HL; Bartolini P; Walker AM
Endocrinology; 2006 Oct; 147(10):4627-37. PubMed ID: 16840547
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL.
Schroeder MD; Brockman JL; Walker AM; Schuler LA
Endocrinology; 2003 Dec; 144(12):5300-7. PubMed ID: 12970160
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation-related vitamin D receptor insensitivity in breast cancer.
Marik R; Fackler M; Gabrielson E; Zeiger MA; Sukumar S; Stearns V; Umbricht CB
Cancer Biol Ther; 2010 Jul; 10(1):44-53. PubMed ID: 20431345
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
12. Prevention of carcinogenesis and inhibition of breast cancer tumor burden by dietary stearate.
Li C; Zhao X; Toline EC; Siegal GP; Evans LM; Ibrahim-Hashim A; Desmond RA; Hardy RW
Carcinogenesis; 2011 Aug; 32(8):1251-8. PubMed ID: 21586513
[TBL] [Abstract][Full Text] [Related]
13. S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist.
Bernichtein S; Kinet S; Jeay S; Llovera M; Madern D; Martial JA; Kelly PA; Goffin V
Endocrinology; 2001 Sep; 142(9):3950-63. PubMed ID: 11517174
[TBL] [Abstract][Full Text] [Related]
14. Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns.
Doig CL; Singh PK; Dhiman VK; Thorne JL; Battaglia S; Sobolewski M; Maguire O; O'Neill LP; Turner BM; McCabe CJ; Smiraglia DJ; Campbell MJ
Carcinogenesis; 2013 Feb; 34(2):248-56. PubMed ID: 23087083
[TBL] [Abstract][Full Text] [Related]
15. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells.
Malloy PJ; Peng L; Wang J; Feldman D
Endocrinology; 2009 Apr; 150(4):1580-7. PubMed ID: 19056816
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression.
Sheng G; Bernabe KQ; Guo J; Warner BW
Gastroenterology; 2006 Jul; 131(1):153-64. PubMed ID: 16831599
[TBL] [Abstract][Full Text] [Related]
18. Opposite effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin on morphology and the expression of prostate specific genes in the normal rat prostate.
Xu X; Wu W; Williams V; Khong A; Chen YH; Deng C; Walker AM
Prostate; 2003 Jan; 54(1):25-33. PubMed ID: 12481252
[TBL] [Abstract][Full Text] [Related]
19. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
Clark DW; Mitra A; Fillmore RA; Jiang WG; Samant RS; Fodstad O; Shevde LA
Curr Cancer Drug Targets; 2008 Aug; 8(5):421-30. PubMed ID: 18690848
[TBL] [Abstract][Full Text] [Related]
20. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
Xu X; Kreye E; Kuo CB; Walker AM
Cancer Res; 2001 Aug; 61(16):6098-104. PubMed ID: 11507059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]